Safety Data Sheet DESMODUR

<####>112000020326
SAFETY DATA SHEET

according to Regulation (EU) No. 1907/2006
Version 2.1
Revision Date 29.06.2011
Print Date 07.09.2012>
1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

Product identifier
Trade name
DESMODUR TRIAL PRODUCT MS 78TF03
Relevant identified uses of the substance or mixture and uses advised against
Use
Di-/polyisocyanate components for the production of

polyurethanes
Identified uses according to Regulation (EU) No. 1907/2006:
- Manufacture of substance
- Use as intermediate for manufacturing other substances and
formulating, repacking and distribution
- Industrial use for flexible foam and elastomers, TPU,
polyamide and synthetic fibres
- Industrial use for rigid foam, coatings and adhesives and
sealants
- Industrial use for composite material based on
wood/mineral/natural fibres
- Industrial use in foundry and other composite material
- Professional end use in rigid foam, coatings, adhesives and
sealants and other composite material
- Consumer end use in rigid foam, coatings and adhesives and
sealants
Details of the supplier of the safety data sheet:

Bayer MaterialScience AG
BMS-IO-S&T-PSRA-PSI Product Safety
51368 Leverkusen
Tel.: +49 214 30 25026
Fax: +49 214 30 9650035
Email: [email protected]
Emergency telephone number: Im Notfall: +49 214 30 99300 (Sicherheitszentrale Bayer)
2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification (1272/2008/CE):
Skin irritation, Category 2 (H315)
Eye irritation, Category 2 (H319)
Sensitization of the respiratory airways, Category 1 (H334)
Sensitization of the skin, Category 1 (H317)
Carcinogenicity, Category 2 (H351)
Specific target organ toxicity (single exposure), Category 3 (H335)
Specific target organ toxicity (repeated exposure), Inhalative, Category 2 (H373)
Classification (2006/121/EC, 1999/45/EC):
Harmful: danger of serious damage to health by prolonged exposure through inhalation.
Limited evidence of a carcinogenic effect.
1/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
May cause sensitization by inhalation and skin contact.

Irritating to eyes, respiratory system and skin.
Label elements
Hazardous components which must be listed on the label
Diphenylmethanediisocyanate-prepolymer
Identification no.:
Diphenylmethane-2,4'-diisocyanate
Identification no.: 615-005-00-9
Labelling (1272/2008/CE):
Danger
Hazard statements:
H315 Causes skin irritation.
H317 May cause an allergic skin reaction.
H319 Causes serious eye irritation.
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
H335 May cause respiratory irritation.
H351 Suspected of causing cancer.
H373 May cause damage to organs through prolonged or repeated exposure if inhaled.
Precautionary statements:
P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray.
P280 Wear protective gloves/ eye protection/ face protection.
P302 + P352 IF ON SKIN: Wash with plenty of soap and water.
P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable
for breathing.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Labelling (2006/121/EC, 1999/45/EC):

Labeling and classification in accordance with the EC Dangerous Preparations Directive
(1999/45/EC) and subsequent amendments
Xn Harmful
EC-Label EC-No.: 227-534-9
R-phrase(s)
R36/37/38
R40
R42/43
R48/20

Harmful: danger of serious damage to health by prolonged exposure through
2/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
inhalation.
S-phrase(s)
S23
S26
S36/37
S45
S60
Do not breathe vapour.

In case of contact with eyes, rinse immediately with plenty of water and seek
medical advice.
Wear suitable protective clothing and gloves.
In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
This material and its container must be disposed of as hazardous waste.
Other hazards
Persons who suffer from hypersensitivity of the respiratory tract (e.g. asthmatics and chronic
bronchitis sufferers) should avoid handling this product. Symptoms affecting the respiratory tract
can also occur several hours after overexposure. Dust, vapors and aerosols are the primary risk
to the respiratory tract.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Type of product: Substance
Diphenylmethane diisocyanate (MDI), modified.
Hazardous components
Concentration [wt.-%]: >= 50 - <= 100
Classification (1272/2008/CE): Sens. Resp. 1 H334 Skin Sens. 1 H317
Classification (67/548/EEC): Xn R42/43
Concentration [wt.-%]: >= 10 - < 20
REACH Registration Number: 01-2119480143-45-0000, 01-2119480143-45-0001, 012119480143-45-0002
CAS-No.: 5873-54-1
EINECS-No.: 227-534-9
Index-No.: 615-005-00-9
Classification (1272/2008/CE): Acute Tox. 4 Inhalative H332 Skin Irrit. 2 H315 Eye Irrit. 2
H319 Sens. Resp. 1 H334 Skin Sens. 1 H317 Carc. 2 H351 STOT SE 3 H335 STOT RE 2
Inhalative H373
Specific threshold concentration (GHS):
Sens. Resp. 1
H334
>= 0,1 %
Eye Irrit. 2
H319
>= 5 %
Skin Irrit. 2
H315
>= 5 %
STOT SE 3
H335
>= 5 %
Classification (67/548/EEC): Carc.Cat.3 R40 Xn R20 R42/43 R48/20 Xi R36/37/38
Specific threshold concentration
Xn
R42
0,1 - < 1 %
Xn
R40, R42/43
1-<5%
Xn
R36/37/38, R40, R42/43
5 - < 10 %
3/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Xn
Xn
R36/37/38, R40, R42/43, R48/20

R20, R36/37/38, R40, R42/43, R48/20
10 - < 25 %
>= 25 %
4. FIRST AID MEASURES

Description of first aid measures
General advice: Soiled, soaked clothing and shoes must be immediately removed,
decontaminated and disposed of.
If inhaled: Take the person into the fresh air and keep him warm, let him rest; if there is difficulty
in breathing, medical advice is required.
In case of skin contact: In the event of contact with the skin, preferably wash with a cleanser
based on polyethylene glycol or with plenty of warm water and soap. Consult a doctor in the
event of a skin reaction.
In case of eye contact: Hold the eyes open and rinse with preferably lukewarm water for a
sufficiently long period of time (at least 10 minutes). Contact an ophthalmologist.
If swallowed: DO NOT induce the patient to vomit, medical advice is required.
Most important symptoms and effects, both acute and delayed

Notes to physician: The product irritates the respiratory tract and may trigger sensitisation of
the skin and respiratory tract. Treatment of acute irritation or bronchial constriction is primarily
symptomatic. Extended medical treatment may be required depending on the degree of
exposure and the severity of the symptoms.
5. Fire-fighting measures
Suitable extinguishing media: Carbon dioxide (CO2), Foam, extinguishing powder, in cases of
larger fires, water spray should be used.
Unsuitable extinguishing media: High volume water jet
Special hazards arising from the substance or mixture:
Burning releases carbon monoxide, carbon dioxide, oxides of nitrogen, isocyanate vapors and
traces of hydrogen cyanide. In the event of fire and/or explosion do not breathe fumes.
Fire in vicinity poses risk of pressure build-up and rupture. Containers at risk from fire should be
cooled with water and, if possible, removed from the danger area.
Advice for fire-fighters:
During fire-fighting respirator with independent air-supply and airtight garment is required.
4/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Do not allow contaminated extinguishing water to enter the soil, ground-water or surface waters.
6. ACCIDENTAL RELEASE MEASURES

Personal precautions, protective equipment and emergency procedures: Put on protective
equipment (see section 8). Ensure adequate ventilation/exhaust extraction. Keep unauthorized
persons away.
Environment related measures: Do not allow to escape into waterways, wastewater or soil.
Methods and material for containment and cleaning up: Remove mechanically; cover the
remainder with wet, absorbent material (e.g. sawdust, chemical binder based on calcium silicate
hydrate, sand). After approx. one hour transfer to waste container and do not seal (evolution of
CO2!). Keep damp in a safe ventilated area for several days.
Reference to other sections: For further disposal measures see section 13.
7. HANDLING AND STORAGE

Precautions for safe handling:
The personal protective measures described in Chapter 8 must be observed. Avoid contact with
skin and eyes and the inhalation of vapor.
Keep away from foodstuffs, drinks and tobacco. Wash hands before breaks and at end of work
and use skin-protecting ointment. Keep working clothes separately. Take off all contaminated
clothing immediately. Decontaminate, destroy and dispose of soiled protective clothing (see
Section 13)
Conditions for safe storage, including any incompatibilities:
Keep container tightly closed and dry. Further information on the storage conditions which must
be observed to preserve quality can be found in our product information sheet.
Storage temperature regarding personal safety: max. 50 C.
VCI storage class (VCI = German Association of the Chemical Industry): 10
8. EXPOSURE CONTROLS/PERSONAL PROTECTION

Threshold value in air defined by TRGS 900 of diphenylmethane-2,4'-diisocyanate is not
established The following airborne exposure limit is intended as a recommendation:
Control parameters
No information on Exposure Limit Values necessary according to EC directive 2006/121/EG
The product may contain traces of phenylisocyanate.
5/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Substance
CAS-No.
Basis
Phenyl isocyanate
103-71-9
TRGS 900
Phenyl isocyanate
103-71-9
TRGS 900
Type
Value
0,01 ppm
0,05
mg/m3
STEL
CL
Ceiling
Limit
Value
1
Remarks
Category I: substances
for which the localized
effect has an assigned
OEL respiratory
passages.
Derived No Effect Level (DNEL) or Derived Minimal Effect Level (DMEL):

Worker (short-term) :
DNEL Dermal - systemic effects: 50 mg/kg body weight/day
DNEL Inhalation - systemic effects: 0,1 mg/m air
DNEL Dermal - local effects: 28,7 mg/cm
DNEL Inhalation - local effects: 0,1 mg/m air
Worker (long-term) :
DNEL Dermal - systemic effects:
No quantitative risk assessment possible.
DNEL Inhalation - systemic effects: 0,05 mg/m air
DNEL Dermal - local effects:
No quantitative risk assessment possible.
DNEL Inhalation - local effects: 0,05 mg/m air
Predicted No Effect Concentration (PNEC):
Freshwater: > 1 mg/l
Marine water: > 0,1 mg/l
Sediment:
Not relevant
Soil: > 1 mg/kg dry weight
STP (sewage-treatment plant): > 1 mg/l
Oral:
Not relevant
Exposure controls
Respiratory protection:
Respiratory protection required in insufficiently ventilated working areas and during spraying. An
air-fed mask, or for short periods of work, a combination of charcoal filter and particulate filter is
recommended.
Hand protection:
Suitable materials for safety gloves; EN 374:
Polychloroprene - CR: thickness >=0,5mm; breakthrough time >=480min.
Nitrile rubber - NBR: thickness >=0,35mm; breakthrough time >=480min.
Butyl rubber - IIR: thickness >=0,5mm; breakthrough time >=480min.
Fluorinated rubber - FKM: thickness >=0,4mm; breakthrough time >=480min.
Recommendation: contaminated gloves should be disposed of.
6/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Eye protection:
Wear eye/face protection.
Skin and body protection:
Wear suitable protective clothing.
Safety precautions for handling freshly molded polyurethane parts: see section 16
9. PHYSICAL AND CHEMICAL PROPERTIES

Information on basic physical and chemical properties
Appearance:
Colour:
Odour:
Odour Threshold:
pH:
Pour point:
Boiling point/boiling range:
Flash point:
liquid
yellowish
almost odourless
not established
not measurable
-6 C
>= 300 C at 1.013 hPa
226 C
Evaporation rate:
Flammability (solid, gas):
Burning number:
Vapour pressure:
not established
not established
not established
4 hPa at 20 C
14 hPa at 50 C
16 hPa at 55 C
Diphenyl-methane-diisocyanate (MDI) <
0,00001 hPa at 20 C
not established
1,145 g/cm at 20 C
immiscible at 15 C
not established
not established
Vapour density:
Density:
Miscibility with water:
Surface tension:
Partition coefficient
(noctanol/water):
Autoignition temperature:
Ignition temperature:
Decomposition temperature:
Viscosity, dynamic:
Explosive properties:
Dust explosion class:
Oxidising properties:
Other information:
ISO 3016
DIN 53171
DIN EN ISO
2719
EG A4
EG A4
EG A4
DIN 51757
not established
485 C
DIN 51794
not established
23.110 mPa.s at 20 C
DIN 53019
not established
not established
not established
The indicated values do not necessarily correspond to the
product specification. Please refer to the technical information
sheet for specification data.
7/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
10. STABILITY AND REACTIVITY

Chemical stability: Polymerises at about 200 C with evolution of CO2.
Possibility of hazardous reactions: Exothermic reaction with amines and alcohols; reacts with
water forming CO2; in closed containers, risk of bursting owing to increase of pressure.
Hazardous decomposition products: No hazardous decomposition products when stored and
handled correctly.
11. TOXICOLOGICAL INFORMATION

Please find below the data available to us:
Information on toxicological effects
Acute toxicity, oral:
LD50 rat, male/female: > 2.000 mg/kg
Method: Directive 67/548/EEC, Annex V, B.1.
Toxicological studies of a comparable product.
Acute toxicity, dermal:
LD50 rabbit, male/female: > 9.400 mg/kg
Method: OECD Test Guideline 402
Studies of a comparable product.
Acute toxicity, inhalation:
LC50 rat, male: 387 mg/m, 4 h
Test atmosphere: dust/mist
The substance was tested in a form (i.e. specific particle size distribution) that is different from
the forms in which the substance is placed on the market and in which it can reasonably be
expected to be used. Therefore, a modified classification for acute inhalation toxicity is justified.
Primary skin irritation:
rabbit
Result: irritating
Primary mucosae irritation:
8/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
rabbit
Result: non-irritant
Effect on the respiratory tract:
Irritating to respiratory system.
Sensitisation:
Classification according to Directive 2006/121/EC Annex VI
Classification: May cause sensitization by inhalation and skin contact.
Skin sensitisation according to Buehler (epicutaneous test): guinea pig
Result: negative
No sensitisation established on guinea-pigs
Skin sensitization (local lymph node assay (LLNA)): mouse
Result: positive
Respiratory sensitization guinea pig
Result: May cause sensitization by inhalation.
Subacute, subchronic and prolonged toxicity:
Application Route: Inhalative
Species: rat, male/female
Dose Levels: 0 - 0,2 - 1 - 6 mg/m3
Exposure duration: 2 a
Frequency of treatment: 6 hours a day, 5 days a week
NOAEL: 0,2 mg/m3
LOAEL (Lowest observable adverse effect level): 1 mg/m3
Target Organs: Lungs
Test substance: as aerosol
Findings: Irritation to nasal cavity and to lungs.
9/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Carcinogenicity:
Species: rat, male/female
Dose Levels: 0 - 0,2 - 1 - 6 mg/m3
Exposure duration: 2 a
Frequency of treatment: 6 hours/day, 5 days/week
Occurrence of tumors in the highest dose group.
Reproductive toxicity/Fertility:
No data available.
Reproductive toxicity/Teratogenicity:
NOAEL (teratogenicity): 12 mg/m3
NOAEL (maternal): 4 mg/m3
Species: rat, female
Dose Levels: 0 - 1 - 4 - 12 mg/m3
Frequency of treatment: 6 hours/day (Exposure duration: 10 days (day 6 - 15 p.c.))
Test period: 20 d
NOAEL (developmental toxicity): 4 mg/m3
Did not show teratogenic effects in animal experiments.
Genotoxicity in vitro:
Test type: Salmonella/microsome test (Ames test)
Test system: Salmonella typhimurium
Metabolic activation: with/without
Result: negative
Test type: Salmonella/microsome test (Ames test)
Test system: Salmonella typhimurium
Metabolic activation: with/without
Result: negative
10/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Genotoxicity in vivo:
Test type: Micronucleus test
Species: rat, male
Application Route: Inhalative (exposure period: 3x1h/day over 3 weeks)
Result: negative
STOT evaluation one-time exposure:
Route of exposure: Inhalation
Target Organs: Respiratory Tract
May cause respiratory irritation.
STOT evaluation repeated exposure:
Route of exposure: Inhalation
Target Organs: Respiratory Tract
May cause damage to organs through prolonged or repeated exposure.
Aspiration toxicity:
Based on available data, the classification criteria are not met.
CMR Assessment:
Carcinogenicity: May cause cancer by inhalation. On the basis of these data classification as
carcinogenic is therefore required.
Mutagenicity: In vitro an in vivo tests did not show mutagenic effects.
Teratogenicity: Did not show teratogenic effects in animal experiments.
Reproductive toxicity/Fertility: Based on available data, the classification criteria are not met.
Toxicology Assessment:
Acute effects: Harmful if inhaled. The product causes irritation of eyes, skin and mucous
membranes.
Sensitization: May cause sensitization by inhalation and skin contact.
Additional information:
Special properties/effects: Over-exposure entails the risk of concentration-dependent irritating
effects on eyes, nose throat, and respiratory tract. Delayed appearance of the complaints and
development of hypersensitivity (difficult breathing, coughing, asthma) are possible.
Hypersensitive persons may suffer from these effects even at low isocyanate concentrations,
including concentrations below the UK Workplace Exposure Limit (WEL). Prolonged contact with
the skin may cause tanning and irritant effects.
Effect on the respiratory tract: In high concentrations vapor of product has irritating effects on
eyes and mucous membranes.
11/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Experience on humans: Irritation of the mucous membranes in the nose, throat and lungs,
dryness of the throat, pressure on the chest, sometimes accompanied by breathing difficulties
and headaches. Possible delayed appearance of the symptoms and allergic reaction in
susceptible persons.
12. ECOLOGICAL INFORMATION

Do not allow to escape into waterways, wastewater or soil.
Please find below the data available to us:
Toxicity
Acute Fish toxicity:
LC50 > 1.000 mg/l
Test type: Acute Fish toxicity
Species: Danio rerio (zebra fish)
Exposure duration: 96 h
Acute toxicity for daphnia:
EC50 > 1.000 mg/l
Species: Daphnia magna (Water flea)
Exposure duration: 24 h
Chronic toxicity to daphnia:
NOEC (Reproduction) > 10 mg/l
Species: Daphnia magna (Water flea)
Exposure duration: 21 d
Acute toxicity for algae:
EC50 > 1.640 mg/l
Tested on: scenedesmus subspicatus Duration of test: 72 h
Acute bacterial toxicity:
EC50 > 100 mg/l
Tested on: activated sludge Duration of test: 3 h
Toxicity to soil dwelling organisms:
12/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
NOEC (mortality) > 1.000 mg/kg
Species: Eisenia fetida (earthworms)
Toxicity to terrestrial plants:
NOEC (seedling emergence) > 1.000 mg/kg
Species: Avena sativa (oats)
NOEC (Growth rate) > 1.000 mg/kg
Species: Avena sativa (oats)
NOEC (seedling emergence) > 1.000 mg/kg
Species: Lactuca sativa (lettuce)
NOEC (Growth rate) > 1.000 mg/kg
Species: Lactuca sativa (lettuce)
Ecotoxicology Assessment:
Acute aquatic toxicity: Based on available data, the classification criteria are not met.
There is no evidence of a chronic aquatic toxicity.
Not expected to adsorb on soil. The substance is graded as non-critical to soil-dwelling
organisms.
Because of the low bacterial toxicity, there is no risk of an adverse effect on the performance of
biological waste water treatment plants.
Persistence and degradability
Biodegradability:
Biodegradation: 0 %, 28 d, Not inherently biodegradable.
Method: OECD Test Guideline 302 C
Stability in water:
13/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Test type: Hydrolysis
Half life: 20 h at 25 C
The substance hydrolyzes rapidly in water.Studies of a comparable product.
Photodegradation:
Test type: Phototransformation in air
sensitizer: OH-radicals
Conctration sensibilisator: 500.000 1/cm3
Rate constant: 1,16E-11 cm3/s
Half-life indirect photolysis: 0,92 d
Method: SRC - AOP (calculation)
After evaporation or exposure to the air, the product will be moderately degraded by
photochemical processes.
Volatility (Henry's Law constant):
Calculated value = 0,0229 Pa*m3/mol
The substance has to be scored as being slightly volatile from water.
Bioaccumulative potential
Bioaccumulation:
Concentration: 0,00008 mg/l
Species: Cyprinus carpio (Carp)
Exposure duration: 28 d Bioconcentration factor (BCF): 200
Method: OECD Test Guideline 305 E
An accumulation in aquatic organisms is not to be expected. Studies of a comparable product.
Mobility in soil
Distribution among environmental compartments:
Adsorption/Soil
not applicable
Environmental distribution:
no data available
Results of PBT and vPvB assessment
Results of PBT assessment: This substance does not meet the criteria for classification as
PBT or vPvB.
Additional information on ecotoxicology:
The product reacts with water at the interface forming CO2 and a solid insoluble product with
high melting point (polyurea). This reaction is accelerated by surfactants (e.g. detergents) or by
watersoluble solvents. Previous experience shows that polyurea is inert and non-degradable.
14/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
13. DISPOSAL CONSIDERATIONS

Dispose in accordance with applicable international, national and local laws, ordinances and
statutes.
For disposal within the EC, the appropriate code according to the European Waste Catalogue
(EWC) should be used.
Waste treatment methods
After final product withdrawal, all residues must be removed from containers (drip-free, powderfree or paste-free). Once the product residues adhering to the walls of the containers have been
rendered harmless, the product and hazard labels must be invalidated. These containers can be
returned for recycling to the appropriate centres set up within the framework of the existing takeback scheme of the chemical industry. Containers must be recycled in compliance with national
legislation and environmental regulations.
None disposal into waste water.
14. TRANSPORT INFORMATION

ADR/RID
Not dangerous goods
ADN
Not dangerous goods
This classification data does not apply to transportation by tanker. If required, additional
information can be requested from the manufacturer.
IATA
Not dangerous goods
IMDG
Not dangerous goods
Special precautions for user
Not dangerous cargo.

Keep dry. Keep away from foodstuffs,
acids and alkalis.
15. REGULATORY INFORMATION

Safety, health and environmental regulations/legislation specific for the substance or mixture
TA Luft List (Germany):
Type: Organic Substances
portion Class 1: 100 %
Water contaminating class (Germany): 1
slightly water endangering
(in accordance with Annex 4 to the Directive on Water-Hazardous Substances)
Any existing national regulations on the handling of isocyanates must be observed.
15/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
A Chemical Safety Assessment has been carried out for:

16. OTHER INFORMATION

Full text of hazardous (H) warnings referred to under sections 2 and 3 of the CLP
classification (1272/2008/CE).
H315
H317
H319
H332
H334
H335
H351
H373
Causes skin irritation.

May cause an allergic skin reaction.
Causes serious eye irritation.
Harmful if inhaled.
May cause allergy or asthma symptoms or breathing difficulties if
inhaled.
May cause respiratory irritation.
Suspected of causing cancer.
May cause damage to organs through prolonged or repeated exposure
if inhaled.
Full text of R-phrases referred to under sections 2 and 3 of the EU classification

(67/548/EEC,1999/45/EC).
R20
R36/37/38
R40
R42/43
R48/20
Harmful by inhalation.
Harmful: danger of serious damage to health by prolonged exposure
through inhalation.
For internal US delivery: Under 172.101,Appendix A,DOT (Department of Transportation) it is

requested: MDI Reportable Quantity (RQ):5000lbs (2270kg).
ISOPA Guidelines for safe loading/unloading, transport and storage of TDI and MDI. ISOPA
Order No.: PSC-0005-GUIDL
Safety precautions for handling freshly molded polyurethane parts:
Depending on the production parameters, any uncovered surfaces of polyurethane moldings
produced using this raw material may contain traces of substances (e. g. starting and reaction
products, catalysts, release agents) with hazardous characteristics. Skin contact with traces of
these substances must be avoided. When demolding or otherwise handling freshly molded
polyurethane parts, protective textile gloves must be worn as a minimum. Their palm and finger
areas should preferably be coated on the outside with nitrilerubber, PVC or polyurethane.
Protective gloves should be changed daily. The wearing of protective clothing suited to the
conditions normally encountered when handling freshly molded polyurethane parts is
recommended.
Changes since the last version are highlighted in the margin. This version replaces all previous
versions.
16/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Further information
The information provided in this Safety Data Sheet is correct to the best of our knowledge,
information and belief at the date of its publication. The information given is designed only as a
guidance for safe handling, use, processing, storage, transportation, disposal and release and is
not to be considered a warranty or quality specification. The information relates only to the
specific material designated and may not be valid for such material used in combination with any
other materials or in any process, unless specified in the text.
17/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Annex - Exposure Scenario

- Manufacture of substance (ES1)
- Use as intermediate for manufacturing other substances and formulating, repacking and
distribution (ES2)
- Industrial use for flexible foam and elastomers, TPU, polyamide and synthetic fibres (ES3)
- Industrial use for rigid foam, coatings and adhesives and sealants (ES4)
- Industrial use for composite material based on wood/mineral/natural fibres (ES5)
- Industrial use in foundry and other composite material (ES6)
- Professional end use in rigid foam, coatings, adhesives and sealants and other composite
material (ES7)
- Consumer end use in rigid foam, coatings and adhesives and sealants (ES8)
1. Short title of Exposure Scenario

- Manufacture of substance (ES1)
Sector of use
Process category
Environmental release
category
: Industrial uses: Uses of substances as such or in preparations

at industrial sites, Manufacture of bulk, large scale chemicals
(including petroleum products), Manufacture of fine chemicals
(SU 3, SU8, SU9)
: Removal of solidified materials by mechanical means in
containers, vessels, blenders, Use in closed process, no
likelihood of exposure, Use in closed, continuous process with
occasional controlled exposure, Use in closed batch process
(synthesis or formulation), Use in batch and other process
(synthesis) where opportunity for exposure arises, Transfer of
substance or preparation (charging/ discharging) from/ to
vessels/ large containers at non-dedicated facilities, Transfer
of substance or preparation (charging/ discharging) from/ to
vessels/ large containers at dedicated facilities, Use as
laboratory reagent (PROC0a, PROC1, PROC2, PROC3,
PROC4, PROC8a, PROC8b, PROC15)
: Manufacture of substances, Formulation of preparations,
Industrial use of monomers for manufacture of thermoplastics
(ERC1, ERC2, ERC6c)
Substance: MDI (ES1)

2. Description of activities/process(es) covered in the Exposure Scenario
Only the uses defined in the short title and the use descriptors listed in chapter 1 above are
regarded as safe/covered within this Exposure Scenario. In case of mixtures the other chapters
may also contain additional information about further uses that are not safe/covered within this
scenario.
3. Operational conditions
Indoor/Outdoor use
Duration and frequency
Workers
Covers daily exposures up to 8 hours (unless stated differently).
18/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Environment
Emission days per year: > 300
4.1 Physical form
Liquid substance (unless stated differently)
Biodegradability: Not biodegradable
4.2 Concentration of substance in the mixture
Covers the percentage of the substance in the product up to 100 % (unless stated differently).
4.3 Amount used per time or per activity
Regional use tonnage (tonnes/year):
2000000
Fraction of EU tonnage used in region:
1
Fraction of regional tonnage used locally:
0,281
Maximum daily site tonnage (kg/day):
1873333
5. Other operational conditions
Used in closed systems
Dry processes
Human factors not influenced by risk management
None identified for this scenario.
Environmental factors not influenced by risk management
Local freshwater dilution factor: 10 (default, used in calculation of worst case scenarios)
Local marine water dilution factor: 100 (default, used in calculation of worst case scenarios)
6. Risk Management Measures
6.1.1 Occupational measures
These measures are for all contributing scenarios at product temperatures BELOW 40 C for pure
MDI or BELOW 45 C for other MDI based substances:
Technical protective measures: Provide a good standard of general ventilation (not less than 3
to 5 air changes per hour).
19/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Personal protective measures: Avoid all skin contact with product, clean up contamination/spills
as soon as they occur. Wear gloves (tested to EN374) if hand contamination likely, wash off any
skin contamination immediately. Provide basic employee training to prevent / minimize exposures
and to report any skin problems that may develop. Use suitable eye protection and gloves. Wear
suitable coveralls to prevent exposure to the skin.
These measures are for all contributing scenarios at product temperatures ABOVE 40 C for
pure MDI or ABOVE 45 C for other MDI based substances:
to 5 air changes per hour). Provide extraction ventilation at points where emissions occur.
Provide extract ventilation to material transfer points and other openings. Handle in a fume
cupboard or under extract ventilation.
suitable coveralls to prevent exposure to the skin. If above technical/organisational control
measures are not feasible, then adopt following PPE: Wear a respirator conforming to EN140
with Type A filter or better.
Additional measures are specific for the following contributing scenarios:

Contributing Scenario
Removal of solidified materials by mechanical means in containers, vessels, blenders,
PROC0a - Covers frequency up to: monthly use.
Personal protective measures: Wear a respirator conforming to EN140 with Type A/P2 filter or
better.
6.1.2 Consumer related measures
No consumer uses identified.
6.2 Environment related measures
- Fraction of emissions to the different environmental compartments:
Release fraction to air from process:
0.000000032
Release fraction to wastewater from process:
20/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
0
Release fraction to soil from process (regional only):
0
- Technical conditions and measures at process level (source) to prevent release:
Common practices vary across sites thus conservative process release estimates used.
- Technical onsite conditions and measures to reduce or limit discharges, air emissions and
releases to soil:
Air: Off-gases are treated by: Incineration, and/or carbon absorption, and/or caustic scrubbing.
Treat air emissions to provide a typical removal efficiency > 99%.
Soil: Soil emission controls are not applicable as there is no direct release to soil.
- Organizational measures to prevent/limit release from site:
Water: Prevent discharge of undissolved substance to or recover from wastewater.
- Conditions and measures related to municipal sewage treatment plant:
Water: Domestic sewage treatment is not assumed.
7. Waste related measures
Not applicable.
8. Prediction of exposure
8.1. Health
RMM efficiencies for inhalation exposure:
Local exhaust ventilation: Variable, reflected in measured data., Respirator conforming to
EN140 with Type A/P2 filter or better: 95%
Short term exposure:
Workers (inhalation)
Method: Measured data has been used for estimation
PROC0a : 0,011 mg/m
PROC 1 : 0,026 mg/m
PROC 2 : 0,026 mg/m
PROC 3 : 0,018 mg/m
PROC 4 : 0,016 mg/m
PROC 8a : 0,058 mg/m
PROC 8b : 0,058 mg/m
PROC 15 : 0,011 mg/m
Workers (dermal)
21/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Method: Qualitative approach used to conclude safe use.

Due to the applied RMMs it is considered that the risks of dermal exposure are sufficiently
controlled.
Long term exposure:
PROC0a : 0,0056 mg/m
PROC 1 : 0,013 mg/m
PROC 2 : 0,013 mg/m
PROC 3 : 0,009 mg/m
PROC 4 : 0,008 mg/m
PROC 15 : 0,006 mg/m
Workers (dermal)
controlled.
8.2. Environment
Method: Used EUSES model
PEC
Air : Not relevant
Freshwater : 0,00687 mg/l
Marine water : 0,000543 mg/l
Sediment : Not relevant
Soil : 0,27 mg/kg dry weight
STP (sewage-treatment plant) : Not relevant
Secondary poisoning : Not relevant
Humans via the environment : Not relevant
Based on the applied RMMs the risk towards humans and the environment is sufficiently
controlled (RCR 1).
9. Guidance to downstream user
Predicted exposures are not expected to exceed the DN(M)EL when the Risk Management
Measures/Operational Conditions outlined in Section 6 are implemented.
Where other Risk Management Measures/Operational Conditions are adopted, then users should
ensure that risks are managed to at least equivalent levels.
Further information on the assumptions contained in this Exposure Scenario can be found at:
www.ISOPA.org - "ISOPA interpretation on selection of Use Descriptors"

- Use as intermediate for manufacturing other substances and formulating, repacking and
distribution (ES2)
Sector of use

22/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Process category
category
at industrial sites, Manufacture of bulk, large scale chemicals

(including petroleum products), Manufacture of fine chemicals,
Formulation [mixing] of preparations and/ or re-packaging
(excluding alloys) (SU 3, SU8, SU9, SU 10)
: Use in closed process, no likelihood of exposure, Use in
closed, continuous process with occasional controlled
exposure, Use in closed batch process (synthesis or
formulation), Use in batch and other process (synthesis)
where opportunity for exposure arises, Mixing or blending in
batch processes for formulation of preparations and articles
(multistage and/ or significant contact), Transfer of substance
or preparation (charging/ discharging) from/ to vessels/ large
containers at non-dedicated facilities, Transfer of substance or
preparation (charging/ discharging) from/ to vessels/ large
containers at dedicated facilities, Transfer of substance or
preparation into small containers (dedicated filling line,
including weighing), Use as laboratory reagent (PROC1,
PROC2, PROC3, PROC4, PROC5, PROC8a, PROC8b,
PROC9, PROC15)
: Formulation of preparations, Formulation in materials,
Industrial use resulting in manufacture of another substance
(use of intermediates) (ERC2, ERC3, ERC6a)

scenario.
Indoor/Outdoor use
Workers
Environment
4.1 Physical form
23/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

520000
1
0,019
Average local daily tonnage (kg/d):
33333
Used in open systems
Dry processes
24/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

Mixing or blending in batch processes for formulation of preparations and articles
(multistage and/ or significant contact), PROC 5
Technical protective measures: Provide extraction ventilation at points where emissions occur.

0.000012
0
0
releases to soil:
Air: No air emission controls required; required removal efficiency is 0%.
25/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Water: Wastewater emission controls are not applicable as there is no direct release to
wastewater.
Not applicable.
Local exhaust ventilation: Variable, reflected in measured data.
PROC 1 : 0,026 mg/m
PROC 2 : 0,026 mg/m
PROC 3 : 0,018 mg/m
PROC 4 : 0,016 mg/m
PROC 5 : 0,025 mg/m
PROC 9 : 0,009 mg/m
PROC 15 : 0,011 mg/m
Workers (dermal)
controlled.
Long term exposure:
PROC 1 : 0,013 mg/m
PROC 2 : 0,013 mg/m
PROC 3 : 0,009 mg/m
PROC 4 : 0,008 mg/m
PROC 5 : 0,012 mg/m
PROC 9 : 0,005 mg/m
PROC 15 : 0,006 mg/m
26/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Workers (dermal)
controlled.
8.2. Environment
PEC
Air : Not relevant
controlled (RCR 1).

- Industrial use for flexible foam and elastomers, TPU, polyamide and synthetic fibres (ES3)
Sector of use
Process category

at industrial sites (SU 3)
(multistage and/ or significant contact), Industrial spraying,
Transfer of substance or preparation (charging/ discharging)
from/ to vessels/ large containers at non-dedicated facilities,
from/ to vessels/ large containers at dedicated facilities,
Transfer of substance or preparation into small containers
(dedicated filling line, including weighing), Production of
preparations or articles by tabletting, compression, extrusion,
pelletisation, Use as laboratory reagent, Low energy
manipulation of substances bound in materials and/ or articles
27/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
category
(PROC1, PROC2, PROC3, PROC4, PROC5, PROC7,

PROC8a, PROC8b, PROC9, PROC14, PROC15, PROC21)
(ERC2, ERC3, ERC6c)

scenario.
Indoor/Outdoor use
Workers
Environment
4.1 Physical form
260000 (flexible foam)
160000 (elastomers, etc.)
1
0,038 (flexible foam)
0,0625 (elastomers, etc.)
33333
28/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

Dry processes
29/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

Industrial spraying, PROC 7
Technical protective measures: Carry out in a vented booth provided with laminar airflow. Carry
out in a vented booth or extracted enclosure. Minimise exposure by extracted full enclosure for
the operation or equipment. Minimise exposure by partial enclosure of the operation or equipment
and provide extract ventilation at openings.
Personal protective measures: If above technical/organisational control measures are not
feasible, then adopt following PPE: Wear a respirator conforming to EN140 with Type A/P2 filter
or better.
0.000012
0
0
releases to soil:
30/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

wastewater.
Not applicable.
8.1. Health
PROC 1 : 0,026 mg/m
PROC 2 : 0,026 mg/m
PROC 3 : 0,018 mg/m
PROC 4 : 0,016 mg/m
PROC 5 : 0,058 mg/m
(flexible foam)
PROC 5 : 0,025 mg/m
(elastomers, etc.)
PROC 7 : 5,0 mg/m
PROC 9 : 0,01 mg/m
PROC 14 : 0,012 mg/m
PROC 15 : 0,011 mg/m
PROC 21 : 0,013 mg/m
Workers (dermal)
controlled.
Long term exposure:
PROC 1 : 0,013 mg/m
PROC 2 : 0,013 mg/m
PROC 3 : 0,009 mg/m
31/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
PROC 4 : 0,008 mg/m

PROC 5 : 0,029 mg/m
(flexible foam)
PROC 5 : 0,012 mg/m
(elastomers, etc.)
PROC 7 : 0,011 mg/m
PROC 9 : 0,005 mg/m
PROC 14 : 0,006 mg/m
PROC 15 : 0,006 mg/m
PROC 21 : 0,006 mg/m
Workers (dermal)
controlled.
8.2. Environment
PEC
Air : Not relevant
controlled (RCR 1).

- Industrial use for rigid foam, coatings and adhesives and sealants (ES4)
Sector of use
Process category

32/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
category

(multistage and/ or significant contact), Industrial spraying,
from/ to vessels/ large containers at non-dedicated facilities,
from/ to vessels/ large containers at dedicated facilities,
Transfer of substance or preparation into small containers
(dedicated filling line, including weighing), Roller application or
brushing, Treatment of articles by dipping and pouring,
Production of preparations or articles by tabletting,
compression, extrusion, pelletisation, Use as laboratory
reagent, Low energy manipulation of substances bound in
materials and/ or articles (PROC1, PROC2, PROC3, PROC4,
PROC5, PROC7, PROC8a, PROC8b, PROC9, PROC10,
PROC13, PROC14, PROC15, PROC21)
Industrial use resulting in inclusion into or onto a matrix,
(ERC2, ERC3, ERC5, ERC6c)

scenario.
Indoor/Outdoor use
Workers
Environment
4.1 Physical form
1120000 (rigid foam)
33/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
60000 (coating)
300000 (adhesives and sealants)
1
0,0089 (rigid foam)
0,167 (coating)
0,033 (adhesives and sealants)
33333
Dry processes
34/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

Industrial spraying, PROC 7
Technical protective measures: Carry out in a vented booth provided with laminar airflow. Carry
out in a vented booth or extracted enclosure. Minimise exposure by extracted full enclosure for
the operation or equipment. Minimise exposure by partial enclosure of the operation or equipment
and provide extract ventilation at openings.
Personal protective measures: If above technical/organisational control measures are not
feasible, then adopt following PPE: Wear a respirator conforming to EN140 with Type A/P2 filter
or better.
35/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
0.000012
0
0
releases to soil:
wastewater.
Not applicable.
8.1. Health
PROC 1 : 0,026 mg/m
PROC 2 : 0,026 mg/m
PROC 3 : 0,018 mg/m
PROC 4 : 0,016 mg/m
PROC 5 : 0,058 mg/m
PROC 7 : 0,022 mg/m
(hotmelt)
PROC 7 : 0,020 mg/m
36/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
(indoor, excluding hotmelt)

PROC 9 : 0,009 mg/m
PROC 10 : 0,034 mg/m
PROC 13 : 0,034 mg/m
PROC 14 : 0,012 mg/m
PROC 15 : 0,011 mg/m
PROC 21 : 0,013 mg/m
Workers (dermal)
controlled.
Long term exposure:
PROC 1 : 0,013 mg/m
PROC 2 : 0,013 mg/m
PROC 3 : 0,009 mg/m
PROC 4 : 0,008 mg/m
PROC 5 : 0,029 mg/m
PROC 7 : 0,011 mg/m
(hotmelt)
PROC 7 : 0,010 mg/m
(indoor, excluding hotmelt)
PROC 9 : 0,005 mg/m
PROC 10 : 0,017 mg/m
PROC 13 : 0,017 mg/m
PROC 14 : 0,006 mg/m
PROC 15 : 0,006 mg/m
PROC 21 : 0,006 mg/m
Workers (dermal)
controlled.
8.2. Environment
PEC
Air : Not relevant
37/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
controlled (RCR 1).

- Industrial use for composite material based on wood/mineral/natural fibres (ES5)
Sector of use
Process category
category

: Removal of solidified materials by mechanical means in
containers, vessels, blenders, Cleaning production line area
with high pressured air, Cleaning production line area with
brush, Use in closed process, no likelihood of exposure, Use
in closed, continuous process with occasional controlled
where opportunity for exposure arises, Transfer of substance
containers at non-dedicated facilities, Transfer of substance or
preparation (charging/ discharging) from/ to vessels/ large
containers at dedicated facilities, Production of preparations or
articles by tabletting, compression, extrusion, pelletisation,
Use as laboratory reagent, Low energy manipulation of
substances bound in materials and/ or articles (PROC0a,
PROC0b, PROC0c, PROC1, PROC2, PROC3, PROC4,
PROC8a, PROC8b, PROC14, PROC15, PROC21)
Industrial use resulting in inclusion into or onto a matrix
(ERC2, ERC3, ERC5)

scenario.
Indoor/Outdoor use
38/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

Workers
Environment
4.1 Physical form
43600
1
0,229
33333
Dry processes
39/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

PROC0a, Removal of solidified materials by mechanical means in containers, vessels,
blenders - Covers frequency up to: monthly use.
better.
Cleaning production line area with high pressured air, PROC0b
better.
40/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
Use in closed, continuous process with occasional controlled exposure, PROC 2
Technical protective measures: Provide extract ventilation to material transfer points and other
openings.
Use in batch and other process (synthesis) where opportunity for exposure arises, PROC
4, Activities in the composite industry close to forming operation
openings. Minimal efficiency exhaust ventilation: > 25%
better.
Production of preparations or articles by tabletting, compression, extrusion, pelletisation,
PROC 14
openings.
Low energy manipulation of substances bound in materials and/ or articles, PROC 21
openings.
0.000012
0
0
41/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

releases to soil:
wastewater.
Not applicable.
8.1. Health
PROC0a : 0,006 mg/m
PROC0b : 0,002 mg/m
PROC0c : 0,28 mg/m
PROC 1 : 0,004 mg/m
PROC 2 : 0,004 mg/m
PROC 3 : 0,004 mg/m
PROC 4 : 0,023 mg/m
Activities in the composite industry close to forming operation
PROC 4 : 0,014 mg/m
Activities in the composite industry close to the production of non-woven or mat
PROC 14 : 0,012 mg/m
PROC 15 : 0,011 mg/m
PROC 21 : 0,001 mg/m
Workers (dermal)
42/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

controlled.
Long term exposure:
PROC0a : 0,006 mg/m
PROC0b : 0,002 mg/m
PROC0c : 0,28 mg/m
PROC 1 : 0,004 mg/m
PROC 2 : 0,004 mg/m
PROC 3 : 0,004 mg/m
PROC 4 : 0,023 mg/m
Activities in the composite industry close to forming operation
PROC 4 : 0,014 mg/m
Activities in the composite industry close to the production of non-woven or mat
PROC 14 : 0,012 mg/m
PROC 15 : 0,011 mg/m
PROC 21 : 0,001 mg/m
Workers (dermal)
controlled.
8.2. Environment
PEC
Air : Not relevant
controlled (RCR 1).
43/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

- Industrial use in foundry and other composite material (ES6)
Sector of use
Process category
category

formulation), Mixing or blending in batch processes for
formulation of preparations and articles (multistage and/ or
significant contact), Transfer of substance or preparation
(charging/ discharging) from/ to vessels/ large containers at
non-dedicated facilities, Transfer of substance or preparation
(charging/ discharging) from/ to vessels/ large containers at
dedicated facilities, Treatment of articles by dipping and
pouring, Production of preparations or articles by tabletting,
compression, extrusion, pelletisation, Use as laboratory
reagent (PROC1, PROC2, PROC3, PROC5, PROC8a,
PROC8b, PROC13, PROC14, PROC15)
Industrial use resulting in inclusion into or onto a matrix,
(ERC2, ERC3, ERC5, ERC6c)

scenario.
Indoor/Outdoor use
Workers
Environment
4.1 Physical form
44/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

56400 (foundry)
1120000 (other composite material)
1
0,177 (foundry)
0,0089 (other composite material)
33333
Dry processes
45/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

Use in closed, continuous process with occasional controlled exposure, PROC 2, Foundry
openings.
Use in closed batch process (synthesis or formulation), PROC 3, Foundry
openings.
(multistage and/ or significant contact), PROC 5, Foundry
openings.
(multistage and/ or significant contact), PROC 5, Other composite material
46/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
PROC 14
Use as laboratory reagent, PROC 15, Foundry
Technical protective measures: Handle in a fume cupboard or under extract ventilation.

0.000012
0
0
releases to soil:
47/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

wastewater.
Not applicable.
8.1. Health
PROC 1 : 0,026 mg/m
PROC 2 : 0,004 mg/m
(foundry)
PROC 2 : 0,004 mg/m
(other composite material)
PROC 3 : 0,004 mg/m
(foundry)
PROC 3 : 0,004 mg/m
PROC 5 : 0,004 mg/m
(foundry)
PROC 5 : 0,004 mg/m
PROC 13 : 0,034 mg/m
PROC 14 : 0,012 mg/m
PROC 15 : 0,011 mg/m
Workers (dermal)
controlled.
Long term exposure:
PROC 1 : 0,013 mg/m
PROC 2 : 0,002 mg/m
(foundry)
PROC 2 : 0,013 mg/m
48/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

PROC 3 : 0,002 mg/m
(foundry)
PROC 3 : 0,009 mg/m
PROC 5 : 0,002 mg/m
(foundry)
PROC 5 : 0,029 mg/m
PROC 13 : 0,017 mg/m
PROC 14 : 0,006 mg/m
PROC 15 : 0,006 mg/m
Workers (dermal)
controlled.
8.2. Environment
PEC
Air : Not relevant
controlled (RCR 1).

- Professional end use in rigid foam, coatings, adhesives and sealants and other composite
material (ES7)
Sector of use
Process category
: Professional uses: Public domain (administration, education,

entertainment, services, craftsmen) (SU 22)
: Use in closed, continuous process with occasional controlled
49/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
category

(multistage and/ or significant contact), Transfer of substance
containers at non-dedicated facilities, Roller application or
brushing, Non industrial spraying, Treatment of articles by
dipping and pouring, Production of preparations or articles by
tabletting, compression, extrusion, pelletisation (PROC2,
PROC3, PROC4, PROC5, PROC8a, PROC10, PROC11,
PROC13, PROC14)
: Wide dispersive indoor use resulting in inclusion into or onto a
matrix, Wide dispersive outdoor use resulting in inclusion into
or onto a matrix (ERC8c, ERC8f)

scenario.
Indoor/Outdoor use
Workers
Environment
Emission days per year: 365
4.1 Physical form
1120000 (rigid foam and other composite material)
60000 (coatings and adhesives and sealants)
1
50/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

0,002
6137 (rigid foam and other composite material)
Dry processes
51/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

(multistage and/ or significant contact), PROC 5, Adhesives and sealings and other
composite material
Non industrial spraying, PROC 11, Outdoor
Technical protective measures: Limit substance content in product to 60%.

better. Wear suitable coveralls to prevent exposure to the skin. Other skin protection measures
such as impervious suits and face shields may be required during high dispersion activities which
are likely to lead to substantial aerosol release, e.g. spraying.
Non industrial spraying, PROC 11, Indoor
Technical protective measures: Limit substance content in product to 60%.

Personal protective measures: Wear a full face respirator conforming to EN140 with Type A/P2
filter or better. Wear suitable coveralls to prevent exposure to the skin. Other skin protection
measures such as impervious suits and face shields may be required during high dispersion
activities which are likely to lead to substantial aerosol release, e.g. spraying.
PROC 14
52/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

0.15
0.01
0.005
releases to soil:
Estimated substance removal from wastewater via domestic sewage treatment is 40%.
Assumed domestic sewage treatment plant effluent flow is 2000 m/d.
Sludge should be incinerated, contained or reclaimed for incineration.
Not applicable.
8.1. Health
53/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

PROC 2 : 0,026 mg/m
PROC 3 : 0,018 mg/m
PROC 4 : 0,012 mg/m
PROC 5 : 0,058 mg/m
PROC 10 : 0,034 mg/m
PROC 11 : 0,064 mg/m
Indoor use
PROC 11 : 0,070 mg/m
Outdoor use
PROC 13 : 0,035 mg/m
PROC 14 : 0,012 mg/m
Workers (dermal)
controlled.
Long term exposure:
PROC 2 : 0,013 mg/m
PROC 3 : 0,009 mg/m
PROC 4 : 0,006 mg/m
PROC 5 : 0,029 mg/m
PROC 10 : 0,017 mg/m
PROC 11 : 0,032 mg/m
Indoor use
PROC 11 : 0,035 mg/m
Outdoor use
PROC 13 : 0,017 mg/m
PROC 14 : 0,006 mg/m
Workers (dermal)
controlled.
8.2. Environment
PEC
Air : Not relevant
(rigid foam)
(coating)
54/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

(adhesives and sealants)
(rigid foam)
(coating)
STP (sewage-treatment plant) : 1,84 mg/l
(rigid foam)
(coating)
controlled (RCR 1).

- Consumer end use in rigid foam, coatings and adhesives and sealants (ES8)
Sector of use
Product category
category
: Consumer uses: Private households (= general public =

consumers) (SU 21)
: Adhesives, sealants, Coatings and paints, thinners, paint
removers, Polymer preparations and compounds (PC1, PC9a,
PC32)
: Wide dispersive indoor use resulting in inclusion into or onto a
matrix, Wide dispersive outdoor use resulting in inclusion into
or onto a matrix (ERC8c, ERC8f)

Rigid Foam, Coatings, Adhesives and sealants
55/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
scenario.
Indoor/Outdoor use
PC1: Adhesives and sealants: Sealant joint
Covers use up to: 1 days/year
For each use event, covers exposure up to: 4 hours/event
Covers skin contact area up to: 2 cm

PC1: Adhesives and sealants: Sealant assembly
PC1: Adhesives and sealants: Adhesive hotmelt

PC9a: Coatings, paints: Use of 2-component paint, solvent rich
PC9a: Coatings, paints: Use of 2-component paint, high solids
PC9a: Coatings, paints: Mixing and loading of 2-component solvent rich paint
For each use event, covers exposure up to: 15 minutes/event
PC9a: Coatings, paints: Mixing and loading of 2-component high solid paint
For each use event, covers exposure up to: 15 minutes/event
PC9a: Coatings, paints: Floor coating high solid
56/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

PC32: Rigids, insulation foams
Environment
Emission days per year: 365
4.1 Physical form
Consumers
Covers use up to 75 g/activity
Environment
57/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
1120000 (rigid foam)

1
0,002
6137 (rigid foam)
Used in open and closed systems
Dry processes
Consumers
Room size: 10 m3
Room size: 20 m3
Room size: 20 m3
Room size: 20 m3
Room size: 20 m3
Room size: 95 m3
Room size: 1 m3
Room size: 34 m3
Room size: 57,5 m3
58/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1
No worker uses identified.

Avoid using without gloves.
0.15
0.01
0.005
releases to soil:
Estimated substance removal from wastewater via domestic sewage treatment is 40%.
Assumed domestic sewage treatment plant effluent flow is 2000 m/d.
Sludge should be incinerated, contained or reclaimed for incineration.
59/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

Not applicable.
8.1. Health
Inhalation exposure
Method: The Consexpo model has been used to estimate consumer exposures unless
otherwise indicated.
PC1: Adhesives and sealants: Sealant joint : 0,024 mg/m/day
PC1: Adhesives and sealants: Sealant assembly : 0,024 mg/m/day
PC1: Adhesives and sealants: Adhesive hotmelt : 0,024 mg/m/day
PC9a: Coatings, paints: Use of 2-component paint, solvent rich : 0,024 mg/m/day
PC9a: Coatings, paints: Use of 2-component paint, high solids : 0,024 mg/m/day
PC9a: Coatings, paints: Mixing and loading of 2-component solvent rich paint : 0,002 mg/m/day
PC9a: Coatings, paints: Mixing and loading of 2-component high solid paint : 0,002 mg/m/day
PC9a: Coatings, paints: Floor coating high solid : 0,024 mg/m/day
PC32: Rigids, insulation foams : 0,006 mg/m/day
Dermal exposure
Method: The Consexpo model has been used to estimate consumer exposures unless
otherwise indicated.
PC1: Adhesives and sealants: Sealant joint : 0,069 mg/kg body weight/day
PC1: Adhesives and sealants: Sealant assembly : 0,023 mg/kg body weight/day
PC1: Adhesives and sealants: Adhesive hotmelt : 0,055 mg/kg body weight/day
PC9a: Coatings, paints: Use of 2-component paint, solvent rich : 0,164 mg/kg body weight/day
PC9a: Coatings, paints: Use of 2-component paint, high solids : 0,152 mg/kg body weight/day
PC9a: Coatings, paints: Mixing and loading of 2-component solvent rich paint : 0,002 mg/kg
body weight/day
PC9a: Coatings, paints: Mixing and loading of 2-component high solid paint : 0,002 mg/kg body
weight/day
PC9a: Coatings, paints: Floor coating high solid : 0,001 mg/kg body weight/day
PC32: Rigids, insulation foams : 0,011 mg/kg body weight/day
8.2. Environment
PEC
Air : Not relevant
(rigid foam)
(coating)
(rigid foam)
(coating)
60/61
BMS_SDS_DE / DE
<####>112000020326
SAFETY DATA SHEET


Version 2.1

(rigid foam)
(coating)
controlled (RCR 1).
61/61
BMS_SDS_DE / DE

Safety Data Sheet DESMODUR

Uploaded by

Copyright:

Available Formats

Safety Data Sheet DESMODUR

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Safety Data Sheet DESMODUR

Uploaded by

Copyright:

Available Formats

<####>112000020326

SAFETY DATA SHEET

Revision Date 29.06.2011

Print Date 07.09.2012>

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

DESMODUR TRIAL PRODUCT MS 78TF03

Di-/polyisocyanate components for the production of

Details of the supplier of the safety data sheet:

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

Print Date 07.09.2012>

May cause sensitization by inhalation and skin contact.

Labelling (2006/121/EC, 1999/45/EC):

Irritating to eyes, respiratory system and skin.

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

Print Date 07.09.2012>

Do not breathe vapour.

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

R36/37/38, R40, R42/43, R48/20

Print Date 07.09.2012>

4. FIRST AID MEASURES

Most important symptoms and effects, both acute and delayed

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

Print Date 07.09.2012>

6. ACCIDENTAL RELEASE MEASURES

7. HANDLING AND STORAGE

8. EXPOSURE CONTROLS/PERSONAL PROTECTION

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

Print Date 07.09.2012>

Derived No Effect Level (DNEL) or Derived Minimal Effect Level (DMEL):

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

Print Date 07.09.2012>

9. PHYSICAL AND CHEMICAL PROPERTIES

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

Print Date 07.09.2012>

10. STABILITY AND REACTIVITY

11. TOXICOLOGICAL INFORMATION

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

Print Date 07.09.2012>

SAFETY DATA SHEET

DESMODUR TRIAL PRODUCT MS 78TF03

Revision Date 29.06.2011

Print Date 07.09.2012>

SAFETY DATA SHEET